Paper2832604
Binaltorphimine-related bivalent ligands and their kappa opioid receptor antagonist selectivity.
Portoghese PS and 4 others. J Med Chem, 1988. Cited by 150 papers, by iCite.
Cite this record
ConductScience Library. Binaltorphimine-related bivalent ligands and their kappa opioid receptor antagonist selectivity. Papers, record 2832604. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2832604
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Binaltorphimine-related bivalent ligands and their kappa opioid receptor antagonist selectivity.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Naltrexone | Major topic |
| Receptors, Opioid | Major topic |
| Animals | |
| Chemical Phenomena | |
| Chemistry | |
| Cyclazocine | |
| Enkephalin, Leucine | |
| Enkephalin, Leucine-2-Alanine | |
| Ethylketocyclazocine | |
| Guinea Pigs | |
| Male | |
| Mice | |
| Models, Molecular | |
| Morphine | |
| Muscle, Smooth | |
| Receptors, Opioid, kappa | |
| Structure-Activity Relationship |
Source PubMed
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 150 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41083597 | Kappa opioid receptor control of motivated behavior revisited. | Neuropsychopharmacology | 2026 | https://conductscience.org/library/papers/41083597 | PubMed |
| 33489124 | Nalfurafine reduces neuroinflammation and drives remyelination in models of CNS demyelinating disease. | Clin Transl Immunology | 2021 | https://conductscience.org/library/papers/33489124 | PubMed |
| 33174064 | Kappa Opioid Receptor Antagonists as Potential Therapeutics for Mood and Substance Use Disorders. | Handb Exp Pharmacol | 2022 | https://conductscience.org/library/papers/33174064 | PubMed |
| 32792571 | Discovery of small molecules that normalize the transcriptome and enhance cysteine cathepsin activity in progranulin-deficient microglia. | Sci Rep | 2020 | https://conductscience.org/library/papers/32792571 | PubMed |
| 32714584 | Targeting opioid receptor signaling in depression: do we need selective κ opioid receptor antagonists? | Neuronal Signal | 2018 | https://conductscience.org/library/papers/32714584 | PubMed |
| 31499001 | 2016 Philip S. Portoghese Medicinal Chemistry Lectureship: Designing Bivalent or Bitopic Molecules for G-Protein Coupled Receptors. The Whole Is Greater Than the Sum of Its Parts. | J Med Chem | 2020 | https://conductscience.org/library/papers/31499001 | PubMed |
| 31162938 | Stereochemistry and innate immune recognition: (+)-norbinaltorphimine targets myeloid differentiation protein 2 and inhibits toll-like receptor 4 signaling. | FASEB J | 2019 | https://conductscience.org/library/papers/31162938 | PubMed |
| 29492614 | The κ-opioid receptor antagonist JDTic decreases ethanol intake in alcohol-preferring AA rats. | Psychopharmacology (Berl) | 2018 | https://conductscience.org/library/papers/29492614 | PubMed |
| 29038479 | Probing ligand recognition of the opioid pan antagonist AT-076 at nociceptin, kappa, mu, and delta opioid receptors through structure-activity relationships. | Sci Rep | 2017 | https://conductscience.org/library/papers/29038479 | PubMed |
| 28128928 | A Direct in Vivo Comparison of the Melanocortin Monovalent Agonist Ac-His-DPhe-Arg-Trp-NH2 versus the Bivalent Agonist Ac-His-DPhe-Arg-Trp-PEDG20-His-DPhe-Arg-Trp-NH2: A Bivalent Advantage. | ACS Chem Neurosci | 2017 | https://conductscience.org/library/papers/28128928 | PubMed |
| 27213169 | Major Depressive Disorder and Kappa Opioid Receptor Antagonists. | Transl Perioper Pain Med | 2016 | https://conductscience.org/library/papers/27213169 | PubMed |
| 26959173 | An in Vitro and in Vivo Investigation of Bivalent Ligands That Display Preferential Binding and Functional Activity for Different Melanocortin Receptor Homodimers. | J Med Chem | 2016 | https://conductscience.org/library/papers/26959173 | PubMed |
| 26005355 | Nalfurafine hydrochloride to treat pruritus: a review. | Clin Cosmet Investig Dermatol | 2015 | https://conductscience.org/library/papers/26005355 | PubMed |
| 24973818 | Pyrrolo- and pyridomorphinans: non-selective opioid antagonists and delta opioid agonists/mu opioid partial agonists. | Bioorg Med Chem | 2014 | https://conductscience.org/library/papers/24973818 | PubMed |
| 22642416 | Long-acting κ opioid antagonists nor-BNI, GNTI and JDTic: pharmacokinetics in mice and lipophilicity. | BMC Pharmacol | 2012 | https://conductscience.org/library/papers/22642416 | PubMed |
| 22538196 | Receptor-targeting mechanisms of pain-causing toxins: How ow? | Toxicon | 2012 | https://conductscience.org/library/papers/22538196 | PubMed |
| 22354464 | Design and synthesis of a bivalent ligand to explore the putative heterodimerization of the mu opioid receptor and the chemokine receptor CCR5. | Org Biomol Chem | 2012 | https://conductscience.org/library/papers/22354464 | PubMed |
| 20137938 | Novel multiple opioid ligands based on 4-aminobenzazepinone (Aba), azepinoindole (Aia) and tetrahydroisoquinoline (Tic) scaffolds. | Bioorg Med Chem Lett | 2010 | https://conductscience.org/library/papers/20137938 | PubMed |
| 19954245 | Synthesis and in vitro opioid receptor functional antagonism of methyl-substituted analogues of (3R)-7-hydroxy-N-[(1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic). | J Med Chem | 2009 | https://conductscience.org/library/papers/19954245 | PubMed |
| 19099466 | Natural products as tools for neuroscience: discovery and development of novel agents to treat drug abuse. | J Nat Prod | 2009 | https://conductscience.org/library/papers/19099466 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2832604
GET https://conductscience.org/api/papers/v1/2832604/cited_by?page=2